Company Performance Metrics
HaemAnalytica develops platelet-based assays and analytics that measure drug effects on bleeding and thrombosis and support cardiovascular and haematology research. The company focuses on multi-parameter, cell-based platelet function assays that can be deployed in clinical trials, diagnostics, drug discovery, and pre-clinical biomedical research.
Its technologies are designed to stratify patients, assess on- and off-target drug effects, and provide clinically actionable platelet function data from multi-centre studies. HaemAnalytica combines standardized wet-lab workflows with centralized flow cytometry and software analysis to generate pharmacologic profiles and phenotype groups. These services are used by biopharmaceutical companies, clinical researchers, and diagnostics developers to de-risk clinical trials and inform precision treatment decisions.
